Long-Term Evaluation of the Risk of Recurrence After Cerebral Sinus-Venous Thrombosis
- 29 June 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 121 (25), 2740-2746
- https://doi.org/10.1161/circulationaha.109.927046
Abstract
Background— The clinical course of cerebral sinus-venous thrombosis (CSVT) is largely unknown because prospective studies with a long follow-up and with the goal to assess thrombosis recurrence rate and predisposing factors for recurrence are lacking. Methods and Results— One hundred forty-five patients with a first CSVT were followed up for a median of 6 years after discontinuation of anticoagulant treatment. End points were recurrent CSVT or other clinical manifestations of venous thromboembolism. CSVT recurred in 5 patients (3%) and other manifestations of venous thromboembolism (deep vein thrombosis of the lower limbs or pulmonary embolism) were seen in 10 additional patients (7%), for a recurrence rate of 2.03 per 100 person-years (95% confidence interval, 1.16 to 3.14) for all manifestations of venous thromboembolism and 0.53 per 100 person-years (95% confidence interval, 0.16 to 1.10) for CSVT. Nearly half of the recurrences occurred within the first year after discontinuation of anticoagulant therapy. Risk factors for recurrent venous thrombosis were male sex (adjusted hazard ratio, 9.66; 95% confidence interval, 2.86 to 32.7) and, for thromboses other than CSVT, severe thrombophilia resulting from antithrombin, protein C, protein S deficiency, anti-phospholipid antibodies, or combined abnormalities (adjusted hazard ratio, 4.71; 95% confidence interval, 1.34 to 16.5). Conclusions— The risk of recurrent CSVT is low and is higher in the first year after discontinuation of anticoagulant treatment and among men. Mild thrombophilia abnormalities are not associated with recurrent CSVT, but severe thrombophilia entails an increased risk of deep vein thrombosis of the lower limbs or pulmonary embolism.Keywords
This publication has 23 references indexed in Scilit:
- Thrombophilia: grading the riskBlood, 2009
- How I treat rare venous thrombosesBlood, 2008
- Cerebral Venous ThrombosisStroke, 2008
- Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosisNeurology, 2008
- EFNS guideline on the treatment of cerebral venous and sinus thrombosisEuropean Journal of Neurology, 2006
- Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysisBlood, 2006
- Thrombosis of the Cerebral Veins and SinusesNew England Journal of Medicine, 2005
- A Review of the Clinical and Diagnostic Utility of Laboratory Tests for the Detection of Congenital ThrombophiliaSeminars in Thrombosis and Hemostasis, 2005
- Hyperhomocysteinemia in cerebral vein thrombosisBlood, 2003
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994